{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:12:31Z","timestamp":1774685551714,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry for Education"},{"name":"Universities and Research (MIUR)"},{"name":"University of Bologna (RFO)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jpba.2018.03.060","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T16:38:35Z","timestamp":1522514315000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8688-2208","authenticated-orcid":false,"given":"Edoardo","family":"Fabini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tramarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-3856","authenticated-orcid":false,"given":"Manuela","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.03.060_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2018.03.060_bib0010","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.jpba.2018.03.060_bib0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","article-title":"The history of the cholinergic hypothesis","volume":"221","author":"Contestabile","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jpba.2018.03.060_bib0020","first-page":"84","article-title":"Pharmacotherapy in the treatment of Alzheimer\u2019s disease: an update","volume":"3","author":"Leonard","year":"2004","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpba.2018.03.060_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5507\/bp.2011.036","article-title":"Cholinesterases, a target of pharmacology and toxicology","volume":"155","author":"Pohanka","year":"2011","journal-title":"Biomed Pap."},{"key":"10.1016\/j.jpba.2018.03.060_bib0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","article-title":"Novel tacrine-benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer's disease: design, synthesis, biological evaluation, and X-ray crystallography","volume":"59","author":"Zha","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/874680","article-title":"Myasthenia gravis: a review","volume":"2012","author":"Jayam Trouth","year":"2012","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jpba.2018.03.060_bib0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug\u2013target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev Drug Discov ."},{"key":"10.1016\/j.jpba.2018.03.060_bib0045","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.4155\/fmc-2016-0183","article-title":"Drug\u2013target interaction kinetics: underutilized in drug optimization?","volume":"8","author":"Copeland","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0050","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1021\/acs.jmedchem.7b00950","article-title":"Structure-Affinity relationships and structure-kinetics relationships of pyrido[2, 1-f]purine-2, 4-dione derivatives as human adenosine A3 receptor antagonists","volume":"60","author":"Xia","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrd.2016.123","article-title":"Biophysics in drug discovery: impact, challenges and opportunities","volume":"15","author":"Renaud","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2018.03.060_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2006.10.040","article-title":"Higher-throughput, label-free, real-time molecular interaction analysis","volume":"361","author":"Rich","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0065","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.3390\/s150510481","article-title":"Surface plasmon resonance: a versatile technique for biosensor applications","volume":"15","author":"Nguyen","year":"2015","journal-title":"Sensors"},{"key":"10.1016\/j.jpba.2018.03.060_bib0070","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.2174\/138161206778743600","article-title":"Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology","volume":"12","author":"Huber","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2018.03.060_bib0075","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1074\/jbc.M006855200","article-title":"Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex","volume":"276","author":"Radi\u0107","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0080","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.1301814110","article-title":"Free energy landscape for the binding process of Huperzine A to acetylcholinesterase","volume":"110","author":"Bai","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jpba.2018.03.060_bib0085","doi-asserted-by":"crossref","first-page":"e22265","DOI":"10.1371\/journal.pone.0022265","article-title":"ENZO a web tool for derivation and evaluation of kinetic models of enzyme catalyzed reactions","volume":"6","author":"Bevc","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2018.03.060_bib0090","article-title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\u2019s disease (review of Technology Appraisal No. 111): a systematic review and economic model","volume":"16","author":"Bond","year":"2012","journal-title":"Health Technol. Assess. (Rockv)."},{"key":"10.1016\/j.jpba.2018.03.060_bib0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1254\/jphs.11R01CR","article-title":"Pharmacological aspects of the acetylcholinesterase inhibitor galantamine","volume":"116","author":"Ago","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2018.03.060_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2018.03.060_bib0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2018.03.060_bib0110","series-title":"All About Albumin","author":"Peters","year":"1995"},{"key":"10.1016\/j.jpba.2018.03.060_bib0115","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: from discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2018.03.060_bib0120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2018.03.060_bib0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpba.2017.03.054","article-title":"Monitoring drug\u2013serum protein interactions for early ADME prediction through Surface Plasmon Resonance technology","volume":"144","author":"Fabini","year":"2017","journal-title":"J. Pharm. Biomed Anal."},{"key":"10.1016\/j.jpba.2018.03.060_bib0130","series-title":"The Art of Immobilization for SPR Sensors","first-page":"117","author":"L\u00f6f\u00e5s","year":"2006"},{"key":"10.1016\/j.jpba.2018.03.060_bib0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<279::AID-JMR473>3.0.CO;2-3","article-title":"Improving biosensor analysis","volume":"12","author":"Myszka","year":"1999","journal-title":"J. Mol Recognit."},{"key":"10.1016\/j.jpba.2018.03.060_bib0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chroma.2006.11.029","article-title":"Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor","volume":"1144","author":"Bartolini","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2018.03.060_bib0145","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/jm991174y","article-title":"Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels","volume":"43","author":"Frostell-Karlsson","year":"2000","journal-title":"J. Med Chem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/abio.2001.5314","article-title":"High-resolution and high-throughput protocols for measuring drug\/human serum albumin interactions using BIACORE","volume":"296","author":"Rich","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpba.2016.01.051","article-title":"Surface plasmon resonance and circular dichroism characterization of cucurbitacins binding to serum albumins for early pharmacokinetic profiling","volume":"122","author":"Fabini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.03.060_bib0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF01705536","article-title":"Properties of acetylcholinesterase reconstituted in liposomes of a different charge","volume":"20","author":"Cho","year":"1995","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpba.2018.03.060_bib0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chroma.2003.11.080","article-title":"Monolithic micro-immobilized-enzyme reactor with human recombinant acetylcholinesterase for on-line inhibition studies","volume":"1031","author":"Bartolini","year":"2004","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2018.03.060_bib0170","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ab.2010.09.009","article-title":"Direct detection of acetylcholinesterase inhibitor binding with an enzyme-based surface plasmon resonance sensor","volume":"408","author":"Milkani","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0175","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1021\/jm070559a","article-title":"Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer\u2019s disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2018.03.060_bib0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.33549\/physiolres.932768","article-title":"The interaction of quaternary reversible acetylcholinesterase inhibitors with the nicotinic receptor","volume":"63","author":"Sepsova","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/j.jpba.2018.03.060_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22122098","article-title":"Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study","volume":"22","author":"Rosenberry","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2018.03.060_bib0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.14712\/18059694.2018.95","article-title":"Acetylcholinesterase and butyrylcholinesterase\u2013important enzymes of human body","volume":"47","author":"Patocka","year":"2004","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.jpba.2018.03.060_bib0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpba.2018.03.060_bib0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1213\/00000539-199010000-00003","article-title":"Pharmacokinetics and pharmacodynamics of edrophonium in elderly surgical patients","volume":"71","author":"Matteo","year":"1990","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jpba.2018.03.060_bib0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jpba.2018.03.060_bib0210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/dmd.110.035964","article-title":"Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young lister hooded rats","volume":"39","author":"Goh","year":"2011","journal-title":"Drug Metab. Dispos."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518304667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518304667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:30:10Z","timestamp":1660757410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518304667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":42,"alternative-id":["S0731708518304667"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.03.060","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.03.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}